| Financial Year |
March 31 2023 |
| Monetary Funds |
1,855,407,827.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
28,713,504.50 |
| Advances to Suppliers |
163,899,060.54 |
| Other Receivables |
369,046,291.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
736,807,303.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,298,098.47 |
| Total Current Assets |
3,199,172,086.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,047,183,879.83 |
| Fixed Assetes |
3,138,787,202.03 |
| Under-construction Projects |
363,534.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,042,742,616.97 |
| R&D expenses |
-- |
| Goodwill |
254,412,831.37 |
| Long-Term Deferred and Prepaid Expenses |
298,703,337.11 |
| Deferred Income Tax Assets |
53,517,349.08 |
| Other Non-Current Assets |
74,760,506.08 |
| Sub-Total of Non-Current Assets |
8,792,111,664.91 |
| Total Assets |
11,991,283,751.05 |
| Short-Term Loans |
3,037,485,947.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
180,526,555.40 |
| Accounts Payable |
1,153,612,597.37 |
| Accounts Received In Advance |
2,493,491.46 |
| Employee Compensation Payable |
177,626,979.97 |
| Taxes Payable |
83,960,333.70 |
| Interest Payable |
-- |
| Dividend Payable |
17,801,812.61 |
| Other payables |
1,919,476,321.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
340,821,541.03 |
| Other Current Liabilities |
4,824,233.46 |
| Sub-Total of Current Liabilities |
6,964,745,138.57 |
| Long-term Loans |
313,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,565,769,423.51 |
| Total Liabilities |
9,530,514,562.08 |
| Paid-In Capital(Or Share Stock) |
520,066,589.00 |
| Capital Surplus |
984,084,192.83 |
| Surplus Reserve |
100,617,374.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
801,309,100.20 |
| Minority Stockholder's Interest |
54,691,932.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,406,077,256.60 |
| Owner's Equity（Stockholder's Equity） |
2,460,769,188.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,991,283,751.05 |
